Jeff Bezos Vs. Elon Musk space contract lawsuit, Novo Nordisk’s famed drug Ozempic could be next contender for Medicare talks, Tesla rival XPeng’s August deliveries surge 43%: Top stories today

tech crunch

Jeff Bezos Vs. Elon Musk: The feud takes center stage in Amazon’s space contract lawsuit

• An institutional investor was prosecuted Amazon.Com Inc. (NASDAQ: AMZN) and its board including jeff bezoson launch contracts awarded to Bezos’ space company, blue core,

• Amazon shareholders Cleveland Bakers and Teamsters Pension Fundclaims Amazon’s board quickly approved the launch agreements project kuiper regardless of competition SpaceX.

• Project Kuiper is Amazon’s cluster of 3,236 low-Earth satellites to cover the globe, vs. led by Elon Musk of spacex starlink Broadband Mega Constellation.

Google has removed the controversial video chat app Chatmate from the Play Store

• alphabet inc (NASDAQ:GOOG) (NASDAQ:GOOG) Google Live video chat app booted out chamet From play store, citing a violation of its user-generated content (UGC) policy. The app, which lets users call stream hosts privately with payment, was pulled from the Play Store in August.

• The decision to remove Chamet has been taken due to Google’s policy of removing apps that primarily feature objectionable UGC. Although Chamette had warnings against airing some of the material, it contained suggestive material and advertisements.

cnbc

Novo Nordisk’s famed drug Ozempic could be contender for Medicare talks

• Novo Nordisk A/S (NYSE:NVO) Ozempic, a highly sought-after diabetes treatment, may soon enter the realm of price negotiations between drugmakers and Medicare.

• Ozempic is poised to become eligible for negotiations when the next batch of drugs is selected in 2025, with a price adjustment taking effect in 2027.

• This spending amount equals some of the drugs under consideration for price discussions this week, out of $98 billion in total Part D spending in 2021.

financial Times

Inflection AI CEO wants ban on Nvidia chip sales: The ethical debate

• Mustafa SuleimanInflection AI CEO and DeepMind co-founder thinks Washington should ban its sales nvidia corporation (NASDAQ: NVDA) chips are a critical component of training advanced artificial intelligence (AI) systems, for buyers who are committed to using technology ethically and responsibly.

• Suleiman suggested that the move could be instrumental in influencing AI practices around the world.

• He proposed that the measure would enable the US to influence the global AI landscape.

After Approving Booking.com-eTravelly Deal, European Regulators Ready To Block The Deal

• EU regulators set to block Sweden’s €1.63bn takeover Etraveli Group by US online travel site Booking Holdings Inc (NASDAQ: BKNG) due to concerns over competition.

• The decision differs from the stance taken by the UK’s Competition and Markets Authority, which approved the deal a year ago.

• EU regulators are concerned that this acquisition will further strengthen Booking’s dominance in the travel industry, potentially hurting competitors.

Benzinga

Rosalind Brewer, CEO of pharmacy chain operator Walgreens, resigns, shares have plunged 47% since her appointment

• Walgreens Boots Alliance Inc (NASDAQ: WBA) CEO has agreed to step down as CEO and board member by August 31, 2023.

• The company said Walgreens’ board and Brewer had mutually agreed that she would step down.

• The board has appointed Ginger Graham, the current lead independent director of WBA, as interim CEO of the company.

• Ms. Brewer has agreed to continue to advise the WBA while the company searches for a permanent CEO.

Tesla rival XPeng’s August deliveries jump 43% due to strong G6 acceleration

• Chinese smart electric vehicle firm Xpeng Inc Shares of XPEV are trading higher after strong deliveries for August.

• The company reported monthly deliveries of 13,690 smart EVs in August, up 24% over the previous month and 43% Y/Y.

• The company’s monthly deliveries of the XPENG G6 stood at 7,068 units, taking the cumulative G6 deliveries to over 11,000 units, crossing the 10,000 mark in just 45 days since deliveries began.

Le Auto’s August deliveries of Le L series models grow by a strong 664%

• Lee Auto Inc (NASDAQ: LI) delivered 34,914 vehicles in August 2023, up 663.8% Y/Y, thanks to the popularity of its three Li L series models, which strengthened its position in China’s NEV and premium vehicle markets.

• From January to August this year, the company said it captured more than 30% market share in the RMB300,000 and above NEV market in China.

• Monthly deliveries of each of the three models in the company’s Li L series exceeded 10,000 vehicles.

Electrification of NIO August: Vehicle deliveries up 81% to 19,329 vehicles

• NIO Inc. (NYSE: NIO) delivered 19,329 vehicles in August 2023, an 81% year-over-year increase.

• The deliveries included 12,015 premium smart electric SUVs and 7,314 premium smart electric sedans.

• NIO expects to deliver 55,000 to 57,000 units in the third quarter, up 74%-80.3% from the year-ago quarter.

Europe Approves Pfizer/BioNTech’s Optimized COVID-19 Vaccine for Upcoming Autumn Vaccination Campaigns

• The European Commission has approved the Cominati XBB.1.5-optimized COVID-19 vaccine, which has been developed BioNTech SE (NASDAQ: BNTX)-Pfizer Inc (NYSE: PFE).

• This is the third adaptation of this vaccine to respond to new COVID-19 variants.

• This vaccine is authorized for adults, children and infants above six months of age.

Bloomberg

Nvidia likely to find relief from supply chain pressure

• nvidia corporation (NASDAQ:NVDA) likely to get some relief from supply chain pressures, report suggests Samsung Electronics Co. (OTC: SSNLF) has won a contract to supply advanced memory chips to the artificial intelligence kingpin.

• The South Korean electronics giant will provide a new generation of HBM3 memory to Nvidia as it struggles to meet growing AI demand.

• Reportedly, Samsung’s chips have successfully passed the quality evaluation by the US chip designer, marking a significant milestone. Supplies of these essential memory chips will likely begin by October.

Washington Post

Amazon’s One Medical CEO departs amid significant leadership change

• CEO Amir Dan Rubin is stepping down from the Concierge primary healthcare startup a medical After serving as CEO for six years and a little over a year after Amazon.Com Inc. (NASDAQ: AMZN) spun off the company. A Medical COO, Trent Green, will replace Rubin.

• Changes are likely to happen in the coming months. Amazon will acquire One Medical in 2022 following the shutdown of its telehealth experiment, Amazon Care.

Don’t miss the real-time alerts on your stocks – Join Benzinga Pro for Free! Try the tool that will help you invest better, faster and smarter.

This article Jeff Bezos Vs. Elon Musk space contract lawsuit, Novo Nordisk’s famed drug Ozempic could be next contender for Medicare talks Tesla rival XPeng’s August deliveries surge 43%: Today’s top stories originally appeared on Benzinga.com

,

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Source: finance.yahoo.com